Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 15 de 15
Filtrar
1.
Artif Organs ; 48(5): 433-443, 2024 May.
Artículo en Inglés | MEDLINE | ID: mdl-38409907

RESUMEN

BACKGROUND: Hypertension is one of the most critical risk factors for cardiovascular disease, which is the leading cause of death in hemodialysis (HD) patients. Medium cut-off (MCO) membrane increases the clearance of medium molecules, which could improve blood pressure (BP) control. This study aimed to compare the effect of MCO and high-flux hemodialysis membranes on BP assessed by ambulatory blood pressure monitoring (ABPM). METHODS: This is a pre-established secondary analysis of a 28-week, randomized, open-label crossover clinical trial. Patients were randomized to HD with MCO or high-flux membranes over 12 weeks, followed by a 4-week washout period, and then switched to the alternate membrane treatment for 12 weeks. ABPM was started before the HD session and ended at least 24 h later in weeks 1, 12, 16, and 28. RESULTS: 32 patients, 59% male, with a mean age of 52.7 years, and 40% with unknown CKD etiology, were enrolled. The dialysis vintage was 8 years, and more than 70% of the patients had hypertension. Regarding 24-h BP control, morning diastolic BP showed an increase in the high-flux compared to stability in the MCO group (interaction effect, p = 0.039). The adjusted ANOVA models showed no significant difference in the morning BP levels between the groups. Considering only the period of the HD session, patients in the MCO, compared to those in the high-flux membrane group, showed greater BP stability during dialysis, characterized by smaller variation in the pre-post HD systolic and minimum systolic BP (treatment effect, p = 0.039, and p = 0.023, respectively). CONCLUSIONS: MCO membrane seems to have a beneficial effect on morning BP and favors better BP stability during HD sessions.


Asunto(s)
Monitoreo Ambulatorio de la Presión Arterial , Cefalosporinas , Hipertensión , Humanos , Masculino , Persona de Mediana Edad , Femenino , Presión Sanguínea , Diálisis Renal/efectos adversos , Hipertensión/diagnóstico , Hipertensión/etiología
4.
Rev Iberoam Micol ; 33(2): 100-3, 2016.
Artículo en Inglés | MEDLINE | ID: mdl-26874585

RESUMEN

BACKGROUND: Hemodialysis has been described as an important risk factor for the development of candidemia in patients suffering from chronic renal failure. AIMS: The aim of this study was to evaluate the epidemiology of candidemia in outpatients with renal replacement therapy (RRT) by hemodialysis where the fungemia clearly represents a healthcare-associated infection. METHODS: We retrospectively collected clinical and laboratory data from patients undergoing at least 3 months of RRT by hemodialysis who developed candidemia within 48h of hospital admission. RESULTS: We identified 14 patients with candidemia with central venous catheters (CVC) in place for 11-277 days before developing fungemia. Deep-seated infection was documented in 6 out of 14 candidiasis cases (43%), including 5 cases of endocarditis (36%). CONCLUSIONS: CVC in patients under RRT should be promptly replaced by fistulas and grafts to avoid bloodstream infections. Facing a case of candidemia, adequate source control and prompt initiation of antifungal therapy are mandatory to avoid morbidity and mortality.


Asunto(s)
Candidiasis Invasiva/epidemiología , Infecciones Relacionadas con Catéteres/epidemiología , Cateterismo Venoso Central/efectos adversos , Infección Hospitalaria/epidemiología , Diálisis Renal/efectos adversos , Adulto , Anciano , Brasil/epidemiología , Candidemia/epidemiología , Candidemia/etiología , Candidemia/microbiología , Candidiasis Invasiva/etiología , Candidiasis Invasiva/microbiología , Infecciones Relacionadas con Catéteres/etiología , Infecciones Relacionadas con Catéteres/microbiología , Catéteres Venosos Centrales/efectos adversos , Catéteres Venosos Centrales/microbiología , Infección Hospitalaria/etiología , Infección Hospitalaria/microbiología , Susceptibilidad a Enfermedades , Endocarditis/epidemiología , Endocarditis/etiología , Endocarditis/microbiología , Endoftalmitis/epidemiología , Endoftalmitis/etiología , Endoftalmitis/microbiología , Infecciones Fúngicas del Ojo/epidemiología , Infecciones Fúngicas del Ojo/etiología , Infecciones Fúngicas del Ojo/microbiología , Femenino , Humanos , Incidencia , Masculino , Persona de Mediana Edad , Diálisis Renal/métodos , Estudios Retrospectivos , Factores de Tiempo , Adulto Joven
5.
BMC Infect Dis ; 15: 158, 2015 Mar 26.
Artículo en Inglés | MEDLINE | ID: mdl-25879516

RESUMEN

BACKGROUND: Infection is the leading cause of morbidity and the second leading cause of mortality in patients on renal replacement therapy. The rates of bloodstream infection in hemodialysis patients vary according to the type of venous access used. Gram-positive bacteria are most frequently isolated in blood cultures of hemodialysis patients. This study evaluated risk factors for the development of bloodstream infections in patients undergoing hemodialysis. METHODS: Risk factors associated with bloodstream infections in patients on hemodialysis were investigated using a case-control study conducted between January 2010 and June 2013. Chronic renal disease patients on hemodialysis who presented with positive blood cultures during the study were considered as cases. Controls were hemodialysis patients from the same institution who did not present with positive blood cultures during the study period. Data were collected from medical records. Logistic regression was used for statistical analysis. RESULTS: There were 162 patients included in the study (81 cases and 81 controls). Gram-positive bacteria were isolated with the highest frequency (72%). In initial logistic regression analysis, variables were hypertension, peritoneal dialysis with previous treatment, type and time of current venous access, type of previous venous access, previous use of antimicrobials, and previous hospitalization related to bloodstream infections. Multiple regression analysis showed that the patients who had a central venous catheter had an 11.2-fold (CI 95%: 5.17-24.29) increased chance of developing bloodstream infections compared with patients who had an arteriovenous fistula for vascular access. Previous hospitalization increased the chance of developing bloodstream infections 6.6-fold (CI 95%: 1.9-23.09). CONCLUSIONS: Infection prevention measures for bloodstream infections related to central venous catheter use should be intensified, as well as judicious use of this route for vascular access for hemodialysis. Reducing exposure to the hospital environment through admission could contribute to a reduction in bloodstream infections in this population.


Asunto(s)
Derivación Arteriovenosa Quirúrgica/estadística & datos numéricos , Bacteriemia/epidemiología , Catéteres Venosos Centrales/estadística & datos numéricos , Hipertensión/epidemiología , Fallo Renal Crónico/terapia , Diálisis Peritoneal/estadística & datos numéricos , Diálisis Renal/estadística & datos numéricos , Infecciones Estafilocócicas/epidemiología , Adulto , Anciano , Brasil/epidemiología , Estudios de Casos y Controles , Femenino , Humanos , Fallo Renal Crónico/epidemiología , Modelos Logísticos , Masculino , Persona de Mediana Edad , Análisis Multivariante , Estudios Retrospectivos , Factores de Riesgo , Staphylococcus aureus
6.
BMC Res Notes ; 7: 882, 2014 Dec 07.
Artículo en Inglés | MEDLINE | ID: mdl-25481650

RESUMEN

BACKGROUND: Infection is the leading cause of morbidity and the second most frequent cause of mortality among patients on renal replacement therapy. A major morbid event in this population is hospitalization because of infection. The aim of this study was to investigate the risk factors for morbidity and mortality related to bloodstream infection (BSI) among patients on hemodialysis. RESULTS: Risk factors for morbidity and mortality related to BSI in patients on hemodialysis were investigated retrospectively by nested case-control, from January 2010 to June 2013. Patients were divided into two groups: those who progressed to hospitalization or death due to BSI (Group 1) and those who developed BSI, but did not progress to the same outcome (Group 2). Data were collected through consultation of patient records. For statistical analysis, logistic regression was used. There were 32 patients in Group 1 and 61 in Group 2. Logistic regression verified that, for each year of age, the chance of death or hospitalization for BSI increased 1.05 times [95% confidence interval (CI): 1.02-1.09]. Patients with BSI caused by Staphylococcus aureus had an 8.67 times higher chance of progressing to death or hospitalization (95% CI: 2.5-30.06). The isolation of multiresistant microorganisms in blood cultures of hemodialysis patients increased morbidity and mortality by 2.75 times (95% CI: 1.01-7.48). CONCLUSION: Independent risk factors for morbidity and mortality among patients after developing BSI during hemodialysis were: age, blood culture positive for S. aureus, and antibiotic resistance. Control measures to prevent microbial dissemination, primarily the multiresistant ones, should be intensified in this population. More studies are needed to standardize specific measures not yet classically standardized, such as collection of surveillance culture samples, contact precautions, and decolonization.


Asunto(s)
Diálisis Renal/efectos adversos , Sepsis/fisiopatología , Anciano , Estudios de Casos y Controles , Femenino , Humanos , Masculino , Persona de Mediana Edad , Factores de Riesgo , Sepsis/etiología , Sepsis/mortalidad
7.
Perit Dial Int ; 33(2): 182-8, 2013.
Artículo en Inglés | MEDLINE | ID: mdl-22942272

RESUMEN

OBJECTIVES: This prospective study, conducted at the dialysis unit of the Nephrology Division, Federal University of Sao Paulo-Oswaldo Ramos Foundation, Brazil, aimed to evaluate whether waist circumference (WC) can predict adiponectin levels in patients undergoing peritoneal dialysis (PD). METHODS: Among 115 patients on PD at a single dialysis center who were evaluated at 6 and 12 months, 57% were men, 31% had diabetes, mean age was 52.8 ± 16.1 years, body mass index was 25 ± 4.3 kg/m(2), and dialysis vintage was 13 months (range: 5 - 33 months). We measured WC at the umbilicus level. Adiponectin was determined by an enzyme-linked immunosorbent assay. RESULTS: At baseline, WC was inversely associated with adiponectin (r = -0.48, p < 0.01). After adjustment for sex, age, diabetes, peritoneal clearance, and residual renal function, WC was an independent determinant of serum adiponectin (ß = -0.52; 95% confidence interval: -0.73 to -0.31; p < 0.001). In the prospective analysis, after adjustment for confounders, changes in WC predicted changes in adiponectin. For each unit increase in WC, adiponectin declined by 0.39 mg/L (p < 0.001). CONCLUSIONS: This study demonstrates that WC is associated with adiponectin and, more importantly, that this simple marker of central adiposity was able to predict changes in adiponectin levels over time.


Asunto(s)
Adiponectina/sangre , Diálisis Peritoneal , Insuficiencia Renal Crónica/sangre , Insuficiencia Renal Crónica/terapia , Circunferencia de la Cintura , Grasa Abdominal , Adiposidad , Adulto , Anciano , Brasil , Femenino , Estudios de Seguimiento , Humanos , Masculino , Persona de Mediana Edad , Estudios Prospectivos , Factores de Tiempo
8.
Nephrol Dial Transplant ; 27(2): 790-5, 2012 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-21948862

RESUMEN

BACKGROUND: Waist circumference (WC) has been well recognized as a surrogate marker of abdominal adiposity. In peritoneal dialysis (PD) patients, however, aspects related to this dialysis modality, such as abdominal distension, presence of catheter and frequent hernia, raise questions regarding the reliability of WC measurements. Herein, we investigated for the first time whether WC is a reliable marker of abdominal adiposity in PD population. METHODS: This study included 107 prevalent PD patients [56% male, age 52 ± 17 years, 35% diabetics, body mass index (BMI) 24.8 ± 3.9 kg/m(2)]. WC measured at umbilicus level was evaluated against the trunk fat assessed by dual-energy x-ray absorptiometry at baseline and after 6 months. All measurements were taken with the empty abdominal cavity. RESULTS: At baseline, a strong correlation of WC with trunk fat (r = 0.81; P < 0.001) was observed. Adjusting for gender, age, dialysis vintage and BMI, WC was independently associated with trunk fat (ß = 0.30; P < 0.001; R(2) = 0.77). The agreement between WC and trunk fat was 0.59 (kappa statistic) and the area under the curve was 0.90. In the prospective evaluation, we observed that changes in WC correlated with changes in trunk fat as well (r = 0.49; P < 0.001). The kappa statistic of 0.48 remained indicative of a moderate agreement between the methods. The receiver operating characteristic curve analysis showed that WC was sensitive to detect changes in trunk fat (area under the curve 0.76). In the logistic regression analysis adjusting for gender, age and BMI, changes in WC were independently associated with changes in trunk fat. CONCLUSION: The simple anthropometric method of WC is a reliable marker of abdominal adiposity in PD patients.


Asunto(s)
Grasa Abdominal/diagnóstico por imagen , Fallo Renal Crónico/terapia , Diálisis Peritoneal/métodos , Circunferencia de la Cintura , Absorciometría de Fotón/métodos , Adulto , Anciano , Biomarcadores/análisis , Análisis Químico de la Sangre , Índice de Masa Corporal , Estudios Transversales , Femenino , Estudios de Seguimiento , Humanos , Fallo Renal Crónico/diagnóstico , Modelos Lineales , Masculino , Persona de Mediana Edad , Análisis Multivariante , Diálisis Peritoneal/efectos adversos , Estudios Prospectivos , Curva ROC , Medición de Riesgo , Sensibilidad y Especificidad , Índice de Severidad de la Enfermedad , Resultado del Tratamiento
9.
Einstein (Säo Paulo) ; 9(1): 70-74, jan.-mar. 2011. tab
Artículo en Inglés | LILACS | ID: biblio-953191

RESUMEN

ABSTRACT Objective: Reuse of hemodialysis filters is a standard practice and the sterilizing chemical most often employed is peracetic acid. Before starting the dialysis session, filters and lines are checked for residual levels of peracetic acid by means of a non-quantitative colorimetric test that is visually interpreted. The objective of this study was to investigate a new quantitative spectrophotometric test for detection of peracetic acid residues. Methods: Peracetic acid solutions were prepared in concentrations ranging from 0.01 to 10 ppm. A reagent (potassium-titanium oxide + sulfuric acid) was added to each sample in proportions varying from 0.08 to 2.00 drops/mL of solution. Optical densities were determined in a spectrophotometer using a 405-nm filter and subjected to visual qualitative test by different observers. Results: A relation between peroxide concentrations and respective optical densities was observed and it was linear with R2 > 0.90 for all reagent/substrate proportions. The peak optical densities were obtained with the reagent/substrate ratio of 0.33 drops/mL, which was later standardized for all further experiments. Both qualitative and quantitative tests yielded a specificity of 100%. The quantitative test was more sensitive than the qualitative test and resulted in higher positive and negative predictive values. There was a difference between observers in the qualitative test and some samples with significant amounts of peroxide were not detected. Conclusion: A quantitative spectrophotometric test may improve detection of residues of peracetic acid when compared to the standard visual qualitative test. This innovation may contribute to the development of safer standards for reuse of hemodialysis filters.


RESUMO Objetivo: A reutilização de filtros de hemodiálise é uma prática disseminada e a substância química esterilizante mais empregada é o ácido peracético. Antes de iniciar a sessão de diálise, os filtros e as linhas são verificados em relação a níveis residuais de ácido peracético por meio de teste colorimétrico não quantitativo, com interpretação visual. O objetivo deste trabalho foi investigar um novo teste espectrofotométrico quantitativo para detecção de resíduos de ácido peracético. Métodos: As soluções de ácido peracético foram preparadas em concentrações que variam de 0,01 a 10 ppm. O reagente (óxido de potássio-titânio + ácido sulfúrico) foi acrescentado a cada amostra em proporções que variaram de 0,08 a 2,00 gotas/mL de solução. As densidades ópticas foram determinadas em um espectrofotômetro com filtro de 405 nm e submetidas a um teste visual qualitativo por diferentes observadores. Resultados: Observou-se a relação linear entre as concentrações de peróxido e as respectivas densidades ópticas com R2 > 0,90 para todas as proporções de reagente/substrato. As maiores densidades ópticas foram obtidas com a proporção reagente/substrato de 0,33 gotas/mL, que foi padronizada para todos os experimentos posteriores. Os testes qualitativos e quantitativos apresentaram especificidade de 100%. O teste quantitativo foi mais sensível do que o qualitativo e apresentou maiores valores preditivos positivos e negativos. Houve uma diferença entre os observadores no teste qualitativo e algumas amostras com quantidade significativa de peróxido não foram detectadas. Conclusão: O teste espectrofotométrico quantitativo pode melhorar a detecção de resíduos de ácido peracético em comparação ao teste visual qualitativo padrão. Essa inovação pode contribuir para o desenvolvimento de padrões mais seguros na reutilização de filtros de hemodiálise.

10.
Einstein (Sao Paulo) ; 9(1): 70-4, 2011 Mar.
Artículo en Inglés, Portugués | MEDLINE | ID: mdl-26760556

RESUMEN

OBJECTIVE: Reuse of hemodialysis filters is a standard practice and the sterilizing chemical most often employed is peracetic acid. Before starting the dialysis session, filters and lines are checked for residual levels of peracetic acid by means of a non-quantitative colorimetric test that is visually interpreted. The objective of this study was to investigate a new quantitative spectrophotometric test for detection of peracetic acid residues. METHODS: Peracetic acid solutions were prepared in concentrations ranging from 0.01 to 10 ppm. A reagent (potassium-titanium oxide + sulfuric acid) was added to each sample in proportions varying from 0.08 to 2.00 drops/mL of solution. Optical densities were determined in a spectrophotometer using a 405-nm filter and subjected to visual qualitative test by different observers. RESULTS: A relation between peroxide concentrations and respective optical densities was observed and it was linear with R2 > 0.90 for all reagent/substrate proportions. The peak optical densities were obtained with the reagent/substrate ratio of 0.33 drops/mL, which was later standardized for all further experiments. Both qualitative and quantitative tests yielded a specificity of 100%. The quantitative test was more sensitive than the qualitative test and resulted in higher positive and negative predictive values. There was a difference between observers in the qualitative test and some samples with significant amounts of peroxide were not detected. CONCLUSION: A quantitative spectrophotometric test may improve detection of residues of peracetic acid when compared to the standard visual qualitative test. This innovation may contribute to the development of safer standards for reuse of hemodialysis filters.

11.
J Ren Nutr ; 18(4): 363-9, 2008 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-18558301

RESUMEN

BACKGROUND: Changes in body fat (BF) were shown to occur over time in peritoneal dialysis (PD) patients. However, the factors associated with BF changes have not been fully investigated in this population. METHODS: We studied 45 patients (25 were male; age, 53, SD +/- 15 years; 21 continuous ambulatory peritoneal dialysis/24 automated peritoneal dialysis; PD vintage, 14 ([range, 3 to 104] months; 40% were diabetic; 31% were previously treated by hemodialysis). Body composition was assessed by dual-energy X-ray absorptiometry and bioelectric impedance analysis, nutritional status was assessed by subjective global assessment, energy intake was assessed by 3-day food records, and resting energy expenditure (REE) was assessed by indirect calorimetry. Glucose absorption, serum bicarbonate, and C-reactive protein were also evaluated. All measurements were performed at baseline and after 12 months. RESULTS: Large variability in BF changes was observed among patients: 53% gained BF (+3.0 +/- 2.8), whereas 47% lost BF (-2.3, SD +/- 1.4). At baseline, groups were similar regarding sex, age, percent diabetics, DP modality, characteristics of peritoneal transport, residual renal function, energy intake, glucose absorption, and REE. However, patients who gained BF had lower BF (16.3, SD +/- 6.9 kg, versus 20.9, SD +/- 6.5 kg; P = .03), had a higher ratio of total energy offered (intake plus absorbed glucose) to REE (1.45, SD +/- 0.39, versus 1.26, SD +/- 0.24; P = .04), and were on PD for a shorter time (10 [range, 3 to 104] versus 20 [range, 4 to 76] months; P = .03). This group also had a higher proportion of malnourished patients (50% versus 19%; P = .03) and of patients previously treated by hemodialysis (46% versus 14%; P = .03). After 12 months, a reduction in the frequency of malnutrition (50% to 25%; P = .02) was observed in the group of patients with increased BF. Patients who lost BF reduced their body cell mass (from 21.7 [SD +/- 5.1 kg] to 20.7 [SD +/- 5.0 kg]; P < .01) and level of serum bicarbonate (from 22.7 [SD +/- 3.7 mmol/L] to 20.9 [SD +/- 3.1 mmol/L]; P < .01). Moreover, this group had an increase in frequency of malnutrition (from 19% to 38%; P = .02), a reduction in the proportion of patients with residual renal function (from 62% to 43%; P = .03), and a higher number of hospitalizations (from 25% to 4%; P = .02) during follow-up. Glucose absorption and C-reactive protein were not associated with BF changes. A regression analysis showed that baseline body mass index was independently associated with a gain of BF (-0.19, SE = 0.09, P = .04), and that hospitalization during follow-up was associated with a loss of BF (2.35, SE = 1.19, P = .04). CONCLUSIONS: Prevalent PD patients exhibited a large variability in BF changes. Baseline body mass index and hospitalizations during follow-up were the most important factors associated with these changes.


Asunto(s)
Tejido Adiposo/metabolismo , Metabolismo Basal/fisiología , Composición Corporal/fisiología , Estado Nutricional , Diálisis Peritoneal , Absorciometría de Fotón/métodos , Calorimetría Indirecta , Registros de Dieta , Impedancia Eléctrica , Ingestión de Energía/fisiología , Metabolismo Energético/fisiología , Femenino , Humanos , Masculino , Persona de Mediana Edad , Valor Predictivo de las Pruebas , Estudios Prospectivos
12.
Toxicon ; 47(7): 774-9, 2006 Jun 01.
Artículo en Inglés | MEDLINE | ID: mdl-16626773

RESUMEN

Microcystin (MC) has been found in several areas of the world. In addition to its hepatotoxicity, microcystin may have an immunomodulatory effect. Considering that patients receiving hemodialysis may be chronically exposed to variable concentrations of MC, and that they present important changes in this immune response, we have assessed the effect of MC on the function of leukocytes. Polymorphonuclear leukocytes isolated from healthy volunteers (HV) and patients receiving hemodialysis (HD) were incubated with microcystin (10 microg/L) for 24h and evaluated for reactive oxygen species production (ROS), phagocytosis and apoptosis. Monocytes incubated with and without LPS (100 ng/mL) and microcystin for 24h were assessed for TNFalpha and IL-10 production. Leukocytes of HV presented an increase in apoptosis rates and leukocytes from HD exhibited a lower production of oxygen-reactive species, both spontaneously and after stimulus with S. aureus, when compared with leukocytes incubated without toxin. Monocytes presented an increase in cytokine production after stimulation by LPS in both groups, but there was no difference between the groups with and without MC that were incubated with or without LPS. Low concentrations of microcystin can induce mild changes in leukocyte function of HV and HDP, particularly in the ability to produce ROS.


Asunto(s)
Leucocitos Mononucleares/citología , Leucocitos Mononucleares/efectos de los fármacos , Péptidos Cíclicos/farmacología , Apoptosis/efectos de los fármacos , Supervivencia Celular/efectos de los fármacos , Relación Dosis-Respuesta a Droga , Humanos , Interleucina-10/metabolismo , Fallo Renal Crónico/terapia , Leucocitos Mononucleares/inmunología , Leucocitos Mononucleares/metabolismo , Microcistinas , Fagocitosis/efectos de los fármacos , Especies Reactivas de Oxígeno/metabolismo , Diálisis Renal , Factor de Necrosis Tumoral alfa/metabolismo
13.
J Ren Nutr ; 16(1): 27-35, 2006 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-16414438

RESUMEN

OBJECTIVE: To evaluate the impact of nutritional parameters at the time of initiation of hemodialysis (HD) on mortality. DESIGN: Retrospective study. SETTING: Dialysis Unit of the Federal University of Sao Paulo, Oswaldo Ramos Foundation. PATIENTS: Three hundred forty-four incident HD patients (60.5% male, 26% diabetic) with the first nutritional evaluation performed before completing 3 months of onset of HD were included. METHODS: The study consisted of baseline measurements of several nutritional parameters (triceps skinfold thickness [TSF], midarm muscle circumference [MAMC], body mass index [BMI], serum albumin, serum creatinine, and protein and energy intake assessed by 3-day food diary) and records of outcome (death) over a period of 10 years. RESULTS: Muscle and/or fat depletion was observed in 51% of the studied patients, according to the percent standard of MAMC and TSF, respectively. Presence of diabetes, age over 60 years, serum albumin < 3.5 g/dL, MAMC adequacy < 90%, protein intake < 1.0 g/kg/d, and energy intake < 25 kcal/kg/d were associated with worse survival. When patients were analyzed according to tertiles of dialysis vintage, BMI > or = 25 (calculated as kg/m2) had a negative impact on survival only in the highest tertile (> 2.45 years). Patients with BMI < 25 and MAMC adequacy > or = 90% showed the best survival over the study period, and those with BMI > or = 25 but MAMC adequacy < 90% had the worst survival (P = .004). In the multivariate survival analysis adjusting for diabetes, advanced age, and hypoalbuminemia, the reduced MAMC (P = .008) and the low energy intake (P = .03) were independent predictors of death in incident HD patients. CONCLUSIONS: Reduced MAMC and low energy intake at the beginning of chronic dialysis are risk factors for mortality. A negative effect of high BMI on survival was associated with reduced MAMC and longer dialysis vintage.


Asunto(s)
Fallo Renal Crónico/terapia , Estado Nutricional , Diálisis Renal/mortalidad , Tejido Adiposo , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Antropometría , Brazo/anatomía & histología , Composición Corporal , Índice de Masa Corporal , Creatinina/sangre , Proteínas en la Dieta/administración & dosificación , Ingestión de Energía , Femenino , Humanos , Fallo Renal Crónico/etiología , Fallo Renal Crónico/mortalidad , Masculino , Persona de Mediana Edad , Músculo Esquelético/anatomía & histología , Modelos de Riesgos Proporcionales , Estudios Retrospectivos , Albúmina Sérica/análisis , Caracteres Sexuales , Grosor de los Pliegues Cutáneos , Tasa de Supervivencia , Factores de Tiempo
14.
Nephrol Dial Transplant ; 21(1): 160-5, 2006 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-16155068

RESUMEN

BACKGROUND: Previous studies have reported that incubation of polymorphonuclear cells (PMN) in uraemic plasma or with different haemodialysis membranes and peritoneal dialysis solutions increases apoptosis in this cell type. In addition, PMN harvested from uraemic patients show a reduced ability to generate superoxide in response to stimuli as well as impaired phagocytosis, chemotaxis and degranulation. The aim of the current study was to investigate the effect of uraemia and dialysis modality on apoptosis and function in freshly harvested non-incubated PMN. METHODS: Polymorphonuclear cells were harvested from 14 chronic haemodialysis (HD) patients, from 14 continuous peritoneal dialysis patients (CAPD), 28 chronic kidney disease (CKD), pre-dialysis patients and from 14 healthy subjects (Controls). In these in vivo experiments, PMN apoptosis was studied by means of flow cytometric analysis of annexin V binding to freshly isolated cells. Polymorphonuclear cell phagocytosis and production of reactive oxygen species by unstimulated or stimulated (S.aureus, fMLP, PMA) cells were also studied by flow cytometry using whole blood. RESULTS: We observed increased PMN apoptosis in CKD patients. CAPD and HD patients displayed PMN apoptosis rates similar to controls. In the HD group, PMN exhibited decreased phagocytosis rates. In contrast, phagocytosis rates in PMN from CAPD were not significantly different from controls. In the CKD and HD groups, apoptosis was inversely correlated with respiratory burst activity and phagocytosis. CONCLUSION: Our results suggest that both uraemia and treatment modality may interfere with PMN apoptosis and function. Dialysis appears to normalize the increased PMN apoptosis rates observed in CKD patients.


Asunto(s)
Apoptosis/fisiología , Fallo Renal Crónico/terapia , Neutrófilos/patología , Especies Reactivas de Oxígeno/metabolismo , Diálisis Renal/efectos adversos , Uremia/terapia , Adulto , Anciano , Análisis de Varianza , Estudios de Casos y Controles , Células Cultivadas , Femenino , Humanos , Fallo Renal Crónico/sangre , Fallo Renal Crónico/diagnóstico , Masculino , Persona de Mediana Edad , Análisis Multivariante , Diálisis Peritoneal Ambulatoria Continua/métodos , Fagocitosis/fisiología , Probabilidad , Valores de Referencia , Diálisis Renal/métodos , Factores de Riesgo , Muestreo , Sensibilidad y Especificidad , Uremia/sangre
15.
Nephrol Nurs J ; 30(3): 295-9, 2003 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-12861897

RESUMEN

Continuous quality improvement (CQI) programs have been instituted in many health care organizations over the last decade. PDCA, a tool composed of planning (P), doing (D), checking (C), and acting (A), has proved to be very useful in the CQI problem-solving process. The use of the PDCA tool described in this article resulted in the successful resolution of a hepatitis B outbreak in a Brazilian hemodialysis population and can serve as a model methodology for improving care in nephrology settings.


Asunto(s)
Modelos Organizacionales , Nefrología/organización & administración , Servicio Ambulatorio en Hospital/organización & administración , Diálisis Renal/normas , Gestión de la Calidad Total/métodos , Brasil/epidemiología , Brotes de Enfermedades/prevención & control , Hepatitis B/epidemiología , Hepatitis B/etiología , Hepatitis B/prevención & control , Humanos , Incidencia , Servicio Ambulatorio en Hospital/estadística & datos numéricos , Evaluación de Programas y Proyectos de Salud , Modelos de Riesgos Proporcionales , Diálisis Renal/efectos adversos , Diálisis Renal/estadística & datos numéricos , Estudios Retrospectivos , Factores de Riesgo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA